The Role of Patient-Provider Agreements in the Context of Risk Evaluation and Mitigation Strategies
Thursday, June 21, 2012
2:00 p.m.-3:00 p.m.
FDA, Silver Spring, MD
For More Information:
James Polli
jpolli@rx.umaryland.edu

Annette Stemhagen, Dr PH, FISPE from United BioSource Corporation will give a lecture on "The Role of Patient-Provider Agreements in the Context of Risk Evaluation and Mitigation Strategies with Emphasis on Opioids".

This event is for CERSI participants and the FDA only.

(The lecture originally scheduled for June 6th has now been rescheduled for June 21st at 2:00 pm.)